Impacts of phototherapy on DNA damage and total oxidant/ antioxidant status in jaundiced newborns

Jaundice is common in newborn babies, and pathologic hyperbilirubinemia isfrequently treated with phototherapy. Although it is considered to be safe, theside effects of phototherapy in newborns are still a matter of debate. In thisstudy, the impacts of two types of phototherapy, conventional fluorescenceand intensive light-emitting diodes (LED), on DNA damage and total oxidant/antioxidant status in jaundiced newborns were assessed. The study groupincluded 40 newborns (gestation age ≥ 37 weeks) on days 2–8 after birth.Newborns were divided into two groups on the basis of need for phototherapy:20 newborns were exposed to conventional phototherapy (Group I); and 20infants were exposed to intensive phototherapy (Group II). Blood sampleswere taken from all infants at admission and after phototherapy to determineplasma 8-hydroxy-2-deoxy-guanosine (8-OH-dG; a marker of DNA damage),total oxidant status (TOS), and total antioxidant capacity (TAC). The oxidativestress index (OSI) was also calculated. Demographic information was recorded,and DNA damage, TOS, and TAC were compared. There were no differences indemographic information between the two groups. There were no significantdifferences in DNA damage, TOS, TAC, and OSI between Groups I and II beforephototherapy (p > 0.05) and no significant differences in DNA damage, TOS,TAC, and OSI between the two groups after phototherapy (p > 0.05). However,the TAC decreased significantly in both groups after phototherapy (p < 0.01).These findings suggest that conventional and intensive phototherapies do notaffect DNA damage and oxidative stress, supporting the safety of its use as thepreferred treatment for jaundiced newborns.

PDF

___

1. Maisels MJ, Gifford K, Antle CE, Leib GR. Jaundice in the healthy newborn infant: a new approach to an old problem. Pediatrics 1988; 81: 505-511.
2. Kaplan M, Hammerman C. Understanding severe hyperbilirubinemia and preventing kernicterus: adjuncts in the interpretation of neonatal serum bilirubin. Clin Chim Acta 2005; 356: 9-21.
3. Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med 2008; 358: 920-928.
4. Lightner DA, McDonagh AF. Molecular mechanisms of phototherapy for neonatal jaundice. Acc Chem Res 1984; 17: 417-424.
5. Porter ML, Dennis BL. Hyperbilirubinemia in the term newborn. Am Fam Physician 2002; 65: 599-606.
6. Vreman HJ, Wong RJ, Stevenson DK. Phototherapy: current methods and future directions. Semin Perinatol 2004; 28: 326-333.
7. Dani C, Martelli E, Reali MF, Bertini G, Panin G, Rubaltelli F. Fiberoptic and conventional phototherapy effects on the skin of premature infants. J Pediatr 2001; 138: 438-440.
8. Maisels MJ. Phototherpy-tradiotional and nontradiotinal. J Perinatol 2001; 21(Suppl 1): S93-S97.
9. Gathwala G, Sharma S. Oxidative stress, phototherapy and the neonate. Indian J Pediatr 2000; 67: 805-808.
10. Aycicek A, Erel O. Total oxidant/antioxidant status in jaundiced newborns before and after phototherapy. J Pediatr (Rio J) 2007; 83: 319-322.
11. Tatli MM, Minnet C, Kocyigit A, Karadag A. Phototherapy increases DNA damage in lymphocytes of hyperbilirubinemic neonates. Mutat Res 2008; 654: 93-95.
12. Kale Y, Aydemir O, Celik U, et al. Effects of phototherapy using different light sources on oxidant and antioxidant status of neonates with jaundice. Early Hum Dev 2013; 89: 957-960.
13. Yahia S, Shabaan AE, Gouida M, et al. Influence of hyperbilirubinemia and phototherapy on markers of genotoxicity and apoptosis in full-term infants. Eur J Pediatr 2015; 174: 459-464.
14. Ramy N, Ghany EA, Alsharany W, et al. Jaundice, phototherapy and DNA damage in full-term neonates J Perinatol 2016; 36: 132-136.
15. Allam A, Ravikiran SR, Baliga BS, Bhat K, Joseph N. Effect of conventional and LED phototherapy on the antioxidant-oxidant status in preterm neonates with jaundice. Indian Pediatr 2017; 54: 644-646.
16. Perrone S, Tataranno ML, Stazzoni G, Buonocore G. Biomarkers of oxidative stress in fetal and neonatal diseases. J Matern Fetal Neonatal Med 2012; 25: 2575-2578.
17. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
18. Goyanes-Villaescusa VJ, Ugarte M, Vazquez A. Sister chromatid exchange in babies treated by phototherapy. Lancet 1977; 2: 1084-1085.
19. Wu FY, Iijima K, Takiguchi D, Nishida A, Higurashi M. Effect of phototherapy on sister-chromatid exchange in infants with Down syndrome. Mutat Res 1992; 283: 65-67.
20. Karadag A, Yesilyurt A, Unal S, et al. A chromosomaleffect study of intensive phototherapy versus conventional phototherapy in newborns with jaundice. Mutat Res 2009; 676: 17-20.
21. Mohamed WW, Niazy WH. Genotoxic effect of phototherapy in term newborn infants with hyperbilirubinemia. J Neonatal Perinatal Med 2012; 5: 381-387.
22. Kahveci H, Dogan H, Karaman A, Caner I, Tastekin A, Ikbal M. Phototherapy causes a transient DNA damage in jaundiced newborns. Drug Chem Toxicol 2013; 36: 88-92.
23. Tsai FJ, Tsai CH, Peng CT, Wang TR. Sister chromatid exchange in Chinese newborn infants treated with phototherapy for more than five days. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1998; 39: 327-329.
24. Rosenstein BS, Ducore JM, Cummings SW. The mechanism of bilirubin-photosensitized DNA strand breakage in human cells exposed to phototherapy light. Mutat Res 1983; 112: 397-406.
25. Schwartz AL, Cole FS, Fiedorek F, et al. Effect of phototherapy on sister chromatid exchange in premature infants. Lancet 1978; 2: 157-158.
26. Hatcher NH, Risemberg HM, Powers MM, Hook EB. Sister-chromatid exchange and phototherapy. Mutat Res 1979; 60: 401-403.
27. Karakukcu C, Ustdal M, Ozturk A, Baskol G, Saraymen R. Assessment of DNA damage and plasma catalase activity in healthy term hyperbilirubinemic infants receiving phototherapy. Mutat Res 2009; 680: 12-16.
28. Atici A, Bozkurt A, Mutlu N, Eskandari HG, Turhan AH. Oxidative stress under phototherapy. Turkiye Klinikleri J Pediatr 2009; 18: 259-263.
29. Demirel G, Uras N, Celik IH, et al. Comparison of total oxidant/antioxidant status in unconjugated hyperbilirubinemia of newborn before and after conventional and LED phototherapy: A prospective randomized controlled trial. Clin Invest Med 2010; 33: E335-E341.
30. Akisu M, Coker C, Tuzun S, Yilmaz D, Kültürsay N. Serum malondialdehyde levels in preterm and fullterm infants undergoing phototherapy. Acta Pediatr 1998; 87: 605-606.
31. Akisu M, Yilmaz D, Tüzün S, Kültürsay N. Antioxidant defense systems in newborns undergoing phototherapy. Indian J Pediatr 1999; 66: 651-655.
32. Kiely M, Morrissey PA, Cogan PF, Kearney PJ. Low molecular weight plasma antioxidants and lipid peroxidation in maternal and cord blood. Eur J Clin Nutr 1999; 53: 861-864.
33. Seidman DS, Moise J, Ergaz Z, et al. A prospective randomized controlled study of phototherapy using blue and blue-green light- emitting devices, and conventional halogen-quartz phototherapy. J Perinatol 2003; 23: 123-127.